LMRI
Lumexa ImagingANasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-20
Current thesis
LMRI combines positive Q1 advanced-imaging volume trends with reiterated 2026 guidance, center additions, and longer-term outpatient-care demand support. The packet also shows a median analyst target of $17.2857 versus the $11.14 anchor price, but target-count breadth is unavailable.
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta +2.8.
What can break
Advanced-imaging volume or reimbursement weakness could impair growth and mix.
Momentum
98
Value
44
Sentiment
60
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $13.00 · Bull $15.50 · Bear $8.50
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-20 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $17.29
Why
Momentum98 · Δ7d +2.8
Value44 · Δ7d +0.0
Sentiment60 · Δ7d +10.7
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
98
26% active weight
Current posture
7d trendFlat
Δ7d
+2.8
Δ21d
+12.8
Value
44
39% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
+0.0
Sentiment
60
34% active weight
Current posture
7d trendImproving
Δ7d
+10.7
Δ21d
+10.9
Why this grade
Composite grade A. Momentum 98.3 / Value 44.0 / Sentiment 60.0
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$1.07B
Beta
-
Shares Out
96.08M
P/E (TTM) · Derived
-22.6
P/S (TTM)
-
P/FCF (TTM)
-
Rev YoY
+3.1%
EPS YoY
-122.0%
Gross Margin
-
Op Margin
-
Net Debt
$903.68M
Current Ratio
1.39
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology